Viking Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2014 | $-1.6M | $-1.6M | — | $6.3K |
| FY2015 | $-8.7M | $-8.7M | — | $2.6M |
| FY2016 | $-11.1M | $-11.1M | — | $1.8M |
| FY2017 | $-14.8M | $-14.8M | — | $1.5M |
| FY2018 | $-18.8M | $-18.8M | — | $2.6M |
| FY2019 | $-24.8M | $-24.8M | — | $3.7M |
| FY2020 | $-21.8M | $-21.8M | — | $5.8M |
| FY2021 | $-47.6M | $-47.6M | — | $6.1M |
| FY2022 | $-48.4M | $-48.4M | — | $8.7M |
| FY2023 | $-73.4M | $-73.4M | — | $16.8M |
| FY2024 | $-87.8M | $-87.8M | — | $29.7M |
| FY2025 | $-278.7M | $-278.7M | — | $40.8M |